FDG PET/CT in monitoring treatment of retroperitoneal fibrosis


Yilmaz S., Tan Y. Z. , Ozhan M., Halac M., Asa S., Sonmezoglu K.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, cilt.31, sa.6, ss.338-339, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Konu: 6
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1016/j.remn.2012.04.001
  • Dergi Adı: REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
  • Sayfa Sayıları: ss.338-339

Özet

Retroperitoneal fibrosis is an uncommon disease characterized by inflammatory fibrosis typically surrounding abdominal aorta and iliac arteries. The glucose analogue F18-fluorodeoxyglucose can be used to image inflammatory cell activity non-invasively by PET. In this report we investigated the usefulness of the FDG PET/CT in the disease activity and therapy response evaluation of retroperitoneal fibrosis. (C) 2012 Elsevier Espana, S.L. and SEMNIM. All rights reserved.